Production (Stage)
Evolutionary Genomics, Inc.
FNAM
$0.0002
-$0.0006-75.00%
OTC PK
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -323.20K | 117.90K | 106.20K | 99.10K | -977.60K |
| Gross Profit | 323.20K | -117.90K | -106.20K | -99.10K | 977.60K |
| SG&A Expenses | 318.00K | 427.80K | 425.30K | 425.90K | 411.40K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 412.20K | 545.70K | 531.40K | 524.90K | 668.10K |
| Operating Income | -412.20K | -545.70K | -531.40K | -524.90K | -668.10K |
| Income Before Tax | -333.80K | -545.30K | -531.10K | -524.90K | -667.80K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -333.80K | -545.30K | -531.10K | -524.90K | -667.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -333.80K | -545.30K | -531.10K | -524.90K | -667.80K |
| EBIT | -412.20K | -545.70K | -531.40K | -524.90K | -668.10K |
| EBITDA | -156.90K | -290.30K | -276.10K | -269.60K | -408.40K |
| EPS Basic | -0.06 | -0.09 | -0.09 | -0.10 | -0.13 |
| Normalized Basic EPS | -0.03 | -0.05 | -0.05 | -0.06 | -0.07 |
| EPS Diluted | -0.06 | -0.09 | -0.09 | -0.10 | -0.13 |
| Normalized Diluted EPS | -0.03 | -0.05 | -0.05 | -0.06 | -0.07 |
| Average Basic Shares Outstanding | 6.66M | 6.66M | 6.63M | 5.89M | 5.88M |
| Average Diluted Shares Outstanding | 6.66M | 6.66M | 6.63M | 5.89M | 5.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |